⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 16, 2008Diabetes CareOpen Access

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes

Carla J. Greenbaum Thomas Mandrup‐Poulsen Paula McGee Tadej Battelino Burkhard Haastert Johnny Ludvigsson Paolo Pozzilli John M. Lachin Hubert Kolb

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

The MMTT is preferred for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Greenbaum et al. (2008) studied this question.

synapsesocial.com/papers/69d926c0c7f0c3ae80a3c200 https://doi.org/10.2337/dc07-2451

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell FunctionPrognostic Study · 2004 · 492 citations
2Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 DiabetesHuman Clinical Trial · 2003 · 76 citations
3The role of measurement reliability in clinical trialsDiagnostic Study · 2004 · 239 citations
4Correlation Coefficients Measured on the Same IndividualsOriginal Research · 1969 · 367 citations
5Effect of Intensive Therapy on Residual β-Cell Function in Patients with Type 1 Diabetes in the Diabetes Control and Complications TrialRCT · 1998 · 546 citations
6Impaired β-Cell Function, Incretin Effect, and Glucagon Suppression in Patients With Type 1 Diabetes Who Have Normal Fasting GlucoseOriginal Research · 2002 · 119 citations
7The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitusOriginal Research · 1991 · 17 citations
8Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 DiabetesEarly-Phase Clinical Trial · 2005 · 1,099 citations
9Common Genetic Variants Near SLC2A2 and Glycemic Response to Glimepiride in the GRADE Comparative Effectiveness Clinical TrialDiabetes Care · 2026
10Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA StudyDiabetes Care · 2026

More from Diabetes Care